FDA pushes cancer trials to include more elderly people

From Science by Jennifer Couzin-Frankel

New guidance aims to improve understanding of drug safety, effectiveness in older adults

Older adults make up a hefty proportion of cancer patients but a much smaller slice of clinical trial participants—a long-standing and vexing problem the U.S. Food and Drug Administration (FDA) wants drug companies to tackle.



Forgotten Password?